First Nebraska Trust Co purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 57,445 shares of the company’s stock, valued at approximately $4,653,000.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Eads & Heald Wealth Management raised its stake in Clorox by 9.5% in the 3rd quarter. Eads & Heald Wealth Management now owns 5,464 shares of the company’s stock valued at $443,000 after acquiring an additional 472 shares during the period. XML Financial LLC lifted its holdings in Clorox by 3.8% during the 3rd quarter. XML Financial LLC now owns 8,475 shares of the company’s stock valued at $687,000 after purchasing an additional 310 shares during the last quarter. Landaas & Co. WI ADV acquired a new stake in Clorox during the 3rd quarter valued at $320,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Clorox during the third quarter worth $4,104,000. Finally, Ipsen Advisor Group LLC boosted its position in Clorox by 7.0% during the third quarter. Ipsen Advisor Group LLC now owns 5,403 shares of the company’s stock worth $438,000 after purchasing an additional 355 shares during the period. Institutional investors own 78.53% of the company’s stock.
More Clorox News
Here are the key news stories impacting Clorox this week:
- Positive Sentiment: Clorox reported adjusted EPS of $1.55, above the $1.07 consensus, and revenue of $1.91 billion versus estimates of $1.88 billion. Sales growth, cost savings and contributions from GOJO supported the quarter. Clorox shares rally after Q1 earnings beat
- Positive Sentiment: The company gave fiscal 2027 adjusted EPS guidance of $5.70–$6.00 and revenue guidance of $7.6–$7.7 billion, broadly in line with or above analyst expectations. Productivity efforts, pricing and GOJO integration savings are intended to help offset cost pressure. Clorox Q1 earnings call highlights
- Neutral Sentiment: Analyst price-target changes were mixed: UBS raised its target to $96 while maintaining a Neutral rating; TD Cowen lifted its target to $88, and JPMorgan raised its target to $86 but retained an Underweight rating. UBS target update
- Negative Sentiment: Clorox expects adjusted earnings near the lower end of its outlook as inflation and other rising costs pressure margins, despite the quarterly beat. Its CEO also pointed to a potential warning sign in consumer spending, which could weigh on demand. Clorox trims outlook on higher costs Clorox CEO economic warning
- Negative Sentiment: Investors may also be weighing debt from a recent acquisition and the potential implications for dividend flexibility. Clorox outlook and dividend concerns
Clorox Stock Performance
CLX opened at $93.77 on Wednesday. The firm has a market cap of $11.34 billion, a P/E ratio of 16.87, a price-to-earnings-growth ratio of 3.00 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The business’s fifty day moving average is $88.00 and its 200-day moving average is $99.83.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 601.88% and a net margin of 9.41%. The business had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. During the same quarter in the previous year, the firm earned $0.85 earnings per share. Clorox’s revenue for the quarter was up 33.3% compared to the same quarter last year. Sell-side analysts expect that The Clorox Company will post 5.68 EPS for the current fiscal year.
Clorox Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 5.3%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox’s dividend payout ratio (DPR) is currently 103.73%.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the stock. Morgan Stanley decreased their price objective on shares of Clorox from $97.00 to $87.00 and set an “equal weight” rating on the stock in a report on Thursday, October 15th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Thursday, October 29th. Wall Street Zen downgraded shares of Clorox from a “hold” rating to a “sell” rating in a report on Saturday, October 3rd. Jefferies Financial Group lowered shares of Clorox from a “buy” rating to a “hold” rating and decreased their price target for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. Finally, TD Cowen reiterated a “hold” rating on shares of Clorox in a research note on Tuesday. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $93.29.
Read Our Latest Analysis on CLX
Clorox Profile
The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.
Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.
Featured Articles
- Five stocks we like better than Clorox
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
